T otal spending for health care in the United States increased 5.3 percent and reached $3.0 trillion in 2014, or $9,523 per person (Exhibit 1). This was faster than the rate of growth in 2013 (2.9 percent), which was the lowest in the fifty-five-year history of the National Health Expenditure Accounts. The acceleration in health spending growth in 2014 followed five consecutive years of historically low growth, which averaged 3.7 percent. Health care spending grew 1.2 percentage points faster than the overall economy in 2014 (when the nominal gross domestic product [GDP] The acceleration in health spending growth in 2014 was primarily driven by faster growth in private health insurance and Medicaid spending in 2014, compared to 2013, as well as by rapid growth in spending on retail prescription drugs (Exhibit 2). Total private health insurance spending growth accelerated from 1.6 percent in 2013 to 4.4 percent in 2014, driven in part by the expansion of health insurance coverage under the Affordable Care Act (ACA), which contributed to faster growth in 2014 benefit spending for prescription drugs, physician and clinical services, and hospital care, compared to 2013. Enrollment in private health insurance increased by 2.2 million in 2014, or 1.2 percent, largely as a result of the net effect of enrollment in health insurance Marketplace plans (Exhibit 3).
Medicaid spending growth also accelerated in 2014, increasing at a rate of 11.0 percent, compared to a growth rate of 5.9 percent in 2013 (Exhibit 3). The acceleration in 2014 was primarily due to provisions in the ACA that expanded eligibility (while providing full federal financing for all newly eligible enrollees) and enhanced doi: 10 
The Affordable Care Act
Since its enactment in 2010, numerous provisions of the ACA have affected the health sector. However, the most significant provisions took effect in 2014, including major coverage expansions through private health insurance and Medicaid. In 2014 Medicaid coverage expanded in some states to most people under age sixty-five with incomes of up to 138 percent of the federal poverty level, 2 and enhanced federal matching payments were provided for newly eligible enrollees. This change in the eligibility criteria is estimated to have led to an additional 6.3 million enrollees in 2014. 3 As a result of this expanded coverage, enrollment in Medicaid increased 13.2 percent in 2014 (up from growth of 1.7 percent in 2013), and spending increased 11.0 percent (up from growth of 5.9 percent in 2013) (Exhibit 3).
Health insurance was also expanded through private insurers, including health plans purchased in the health insurance Marketplaces. The Marketplaces allow individuals and small businesses (those with fewer than 100 employees) to purchase policies that by law must guarantee availability of coverage, prohibit annual dollar limits on coverage received, and create an essential health benefits package that provides comprehensive health benefits. Marketplace average monthly enrollment was 5.4 million in 2014. 4, 5 Additionally, the ACA provides health insurance premium tax credits and costsharing subsidies to eligible individuals and imposes new fees on the health insurance sector. 6 Other provisions of the ACA that took effect before 2014 continued to affect overall health spending. These include changes to Medicare and Medicaid provider payments, increased Medicaid prescription drug rebates, reductions to the size of the Medicare Part D coverage gap, prescription drug industry fees, and implementation of the medical loss ratio requirement for private insurers. 7 
Factors Accounting For Growth
Aggregate national health spending grew 5.3 percent in 2014, or 4.5 percent per capita (Exhibit 1). This per capita growth can be examined further by analyzing the impact of medical price inflation (which includes overall economywide price inflation and medical-specific price inflation) and nonprice factors, such as shifts in the age and sex mix of the population and residual use and intensity of services. Of the 4.5 percent increase in per capita health spending in 2014, changes in the age and sex mix of the population accounted for 0.6 percentage point, medical price inflation accounted for 1.8 percentage points, and the change in residual use and intensity accounted for the remaining 2.1 percentage points (Exhibit 4).
There was a substantial increase in the portion of health spending growth attributed to residual use and intensity of services in 2014. In 2013 the growth rate for this factor was just 0.2 percent, but it accelerated to 2.1 percent in 2014 and accounted for almost half of per capita health spending growth. As Medicaid and private health insurance coverage expanded, faster growth in residual use and intensity of services occurred for almost all health care goods and services in 2014 compared to 2013, particularly for hospital care, physician and clinical services, and prescription drugs.
Medical price growth increased at a rate of 1.8 percent in 2014, following growth of 1.3 percent in 2013. Economywide inflation (as measured by the GDP price index) increased 1.6 percent in both 2013 and 2014, while medicalspecific price growth increased 0.1 percent after a decline of 0.3 percent in 2013. Faster price growth for expenditures outside of personal health care (such as the net cost of insurance and investment in structures and equipment) more than offset a slight deceleration in overall prices for personal health care services, such as for hospital care and other professional services.
Revisions To The National Health Expenditure Accounts
The health spending estimates in this article differ in two ways from those released December 3, 2014. 7 First, these estimates reflect new and revised source data that were unavailable for previous vintages of the National Health Expendi-
Exhibit 4
Factors Accounting For Growth In Per Capita National Health Expenditures, Selected Calendar Years 2004-14 SOURCE Centers for Medicare and Medicaid Services, Office of the Actuary, National Health Statistics Group. NOTE Medical price growth, which includes economywide and excess medical-specific price growth (or changes in medical-specific prices in excess of economywide inflation), is calculated using the chain-weighted national health expenditures (NHE) deflator for NHE. "Residual use and intensity" is calculated by removing the effects of population, age and sex factors, and price growth from the nominal expenditure level.
ture Accounts. In particular, the 2013 growth rate for national health spending was revised down from 3.6 percent to 2.9 percent, mainly because of downward revisions to the estimates for physician and clinical services and hospital spending.
Second, every five years the National Health
In total, changes due to the comprehensive and routine revisions resulted in a downward revision of $18.3 billion in 2012, or 0.7 percent of national health expenditures, compared to last year's report. In addition, the GDP was revised down by $7.9 billion for 2012. 9 As a result, the health spending share of GDP for 2012 is now reported as 17.3 percent, down from the previously reported share of 17.4 percent. 7 
Sponsors Of Health Care
The main sponsors of health care are households, private businesses, the federal government, and state and local governments that finance the nation's health care bill. In 2014 households and the federal government accounted for the largest shares of spending (28 percent each), followed by private businesses (20 Health spending by private businesses, which includes employers' contributions to private health insurance premiums and other health care programs, increased 4.2 percent in 2014, compared to a growth rate of 1.7 percent in 2013. Despite the accelerated growth in 2014, private businesses continued to account for 20 percent of total health spending-a share that has remained stable since 2010. The major driver of growth in private business spending in 2014 was employer contributions to private health insurance premiums, which accounted for a 76 percent share of this category and increased 3. Expenditures for private health insurance medical benefits grew 4.1 percent in 2014, accelerating from growth of 1.5 percent in 2013. This acceleration was driven by faster growth in spending for retail prescription drugs, physician and clinical services, and hospital care in 2014, compared to 2013. Rapid growth in retail prescription drug spending in 2014 was due in part to the introduction of new drug treatments for hepatitis C. 1 Faster growth in private health insurance expenditures for physician and clinical services and hospital care in 2014, compared to 2013, was driven by increased use mainly due to enrollment growth.
Although spending for private health insurance benefits increased in 2014, their share of total private health insurance spending was down slightly, from 87.9 percent in 2013 to 87.7 percent in 2014. Growth in the net cost of insurance, or the difference between revenue and benefits, was 6.6 percent in 2014 and primarily reflected fees associated with the ACA, as well as other administrative costs related to increased private health insurance enrollment. Per enrollee Medicaid spending declined at a rate of 2.0 percent in 2014 after growing 4.1 percent in 2013, as the newly insured tended to be lower-cost individuals. 2 The share of total Medicaid enrollees who were adults and children (groups that are generally less expensive than the aged and disabled) increased in 2014, compared with 2013. 2 Faster growth in spending for government administration and the net cost of insurance was also a contributor to the overall acceleration in Medicaid spending growth in 2014, with expenditures increasing 30.4 percent after growing 13.8 percent in 2013. This faster rate of growth in 2014 was driven primarily by increased enrollment, particularly for managed care, as new enrollees tended to join Medicaid managed care plans.
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Medicaid spending for physician and clinical services, hospital care, and prescription drugs increased at a faster rate in 2014 than in the previous year. Expenditures for physician and clinical services grew 22.8 percent, up from growth of 11.0 percent in 2013, because of both increased enrollment and ACA provisions that required states to pay fees to primary care providers that were at least equal to the fees that Medicare paid to primary care providers in 2013 and 2014. Medicare per enrollee spending growth accelerated in 2014, increasing 2.4 percent after increasing just 0.1 percent in 2012 and declining 0.2 percent in 2013. 11 In the two years prior to 2014, slower and declining per enrollee expenditures were influenced by a combination of onetime payment reductions and policies put in place by the ACA and budget sequestration.
Faster growth in per enrollee spending in 2014 was also affected by increased use of health care goods and services, especially prescription drugs and physician services. Following growth of 9.5 percent in 2013, Medicare prescription drug spending increased 16.9 percent in 2014, primarily because of the use of new and expensive specialty drugs, including those used in treating hepatitis C. 12 Additionally, growth in Medicare spending for physician and clinical services accelerated in 2014-increasing 5.0 percent from 2.9 percent in 2013-because of a larger increase in the physician fee schedule payment update and an increase in the volume and intensity of services.
Also contributing to the increase in total Medicare expenditures in 2014 was faster spending growth for government administration and the net cost of insurance, which increased 8. 
Out-Of-Pocket Spending
Total out-of-pocket spending-which includes direct consumer payments such as copayments, deductibles, coinsurance, and any spending on noncovered services-increased 1.3 percent in 2014, reaching $329.8 billion, and accounted for 11 percent of total health care expenditures. Following growth of 2.1 percent in 2013, the slightly slower growth in out-of-pocket spending in 2014 was affected by changes in health care coverage, most notably fewer out-of-pocket payments by those without insurance and more by those with Medicaid and directly purchased coverage. 14 Compared to 2013, faster out-of-pocket spending growth in 2014 for prescription drugs (particularly because of increased use of high-cost specialty drugs) and other professional services was more than offset by a decline in out-of-pocket spending for hospital services and slower growth in such spending for physician and clinical services (both of which were due to increased insurance coverage).
Retail Prescription Drugs
In 2014 growth in total retail prescription drug expenditures accelerated sharply, increasing 12.2 percent to $297.7 billion. This rate compares to growth of 2.4 percent in 2013 and 0.2 percent in 2012 and represents the largest annual increase since 2002. The strong growth in prescription drug expenditures in 2014 was caused by increased spending on new medicines (particularly for specialty drugs such as those used to treat hepatitis C), a smaller impact from patent expirations than in previous years, and price increases for brand-name drugs. 1 The single largest driver of growth in specialty drug spending in 2014 was the impact of new treatments for hepatitis C, which contributed $11.3 billion in new spending. 1 Prescription drug price growth continued to be affected by faster growth in 2014 (compared to 2013) in prices for brand-name medications and declines in prices for generic drugs. 15 Because generic drugs cost substantially less than their brand-name counterparts, 16 it is not uncommon to see increases in the generic dispensing rate, especially when blockbuster drugs lose their patent protection. In 2014 the generic dispensing rate was 81.7 percent, up from 80. Out-of-pocket spending on hospital services, which includes expenditures for copayments and deductibles, declined 4.1 percent in 2014, down from a growth rate of 4.7 percent in 2013. This decline was influenced by expanded coverage through Medicaid and private health insurance.
Physician And Clinical Services
Spending for physician and clinical services grew 4.6 percent in 2014, reaching $603.7 billion. This was an acceleration from 2013, when spending grew at a historically low rate of 2.5 percent.
As with hospital services and retail prescription drugs, expenditure growth for physician and clinical services accelerated in 2014 for Medicaid, private health insurance, and Medicare. Spending for Medicaid physician and clinical services-which increased 22.8 percent in 2014, compared to 11.0 percent in 2013-was influenced by expanded Medicaid enrollment eligibility under the ACA and increased primary care provider fees that affected growth in 2013 and, to a greater extent, in 2014. 10 Private health insurance spending also contributed to the acceleration in expenditure growth for total physician and clinical services, increasing 1. 12 Nonprice factors also grew faster in 2014-driven, in part, by coverage expansions resulting from the ACA, particularly for Medicaid. 23 
Conclusion
The expansion of insurance coverage, particularly through Medicaid and private health insurance, and rapid growth in retail prescription drug spending fueled a 5.3 percent increase in total national health care expenditures in 2014. This increase compares to historically low health spending growth from 2009 to 2013, when growth averaged only 3.7 percent. Health expenditures grew faster than the overall economy in 2014, as the GDP increased 4.1 percent. As a result, the health spending share of GDP increased from 17.3 percent in 2013 to 17.5 percent in 2014. The return to faster growth and an increased share of GDP in 2014 was largely influenced by the coverage expansions of the Affordable Care Act. But how the health sector responds to the evolving access and incentive landscape, as well as underlying economic conditions, will determine the future trajectory of health spend- 
